IP Library Granted Patent US 11,076,984
Granted Patent B2
US 11,076,984 · App. 15/911,315 · Granted Aug 3, 2021

Method of performing subretinal drainage and agent delivery

Inventors: Daniel W. Price (Loveland, OH); Brendan J. Oberkircher (Cincinnati, OH); Daniel J. Prenger (Loveland, OH); Geoffrey King (Cincinnati, OH); Isaac J. Khan (Bridgewater, NJ); Michael F. Keane (Downingtown, PA); Benjamin L. Ko (Cincinnati, OH)
Assignee: GYROSCOPE THERAPEUTICS LIMITED
A61F9/0017A61F9/007A61F9/0008A61F9/0026A61F9/00727A61F9/00736A61F9/00781A61M5/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,076,984
App. No.
15/911,315
Granted
Aug 3, 2021
Kind
B2
Abstract

A method includes inserting a flexible cannula between a sclera and a choroid of an eye. The needle is advanced from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye. The needle is used to aspirate fluid from the subretinal space. The fluid may be present from a retinal detachment, a macular hemorrhage, or other condition present before the procedure begins. The method may further include injecting the fluid in the subretinal space via the needle, in which case the fluid may be a balanced salt solution or other bleb fluid. The method may further include injecting a therapeutic agent into the subretinal space after aspirating the bleb fluid. The volume of injected bleb fluid may be greater than the volume of injected therapeutic agent.

Claims (36)

1. A method, comprising:

(a) inserting a flexible cannula having a needle retracted therein into a space between a sclera and a choroid of an eye;

(b) arresting insertion of the flexible cannula into the space between the sclera and the choroid of the eye;

(c) after arresting insertion of the flexible cannula, advancing the needle from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye;

(d) aspirating fluid from the subretinal space via the needle; and

(e) after aspirating fluid from the subretinal space via the needle, injecting a therapeutic agent into the subretinal space via the needle.

2. The method of claim 1 , further comprises performing a sclerotomy in the sclera to thereby form an incision through the sclera, wherein the act of inserting the flexible cannula into the space between the sclera and the choroid comprises inserting the cannula through the incision.

3. The method of claim 1 , further comprising securing a guide assembly to the eye, wherein the act of inserting the flexible cannula into the space between the sclera and the choroid comprises inserting the cannula through the guide assembly.

4. The method of claim 1 , wherein the distal end of the flexible cannula includes a transversely oriented opening, wherein the act of advancing the needle comprises advancing the needle out through the transversely oriented opening.

5. The method of claim 1 , wherein the needle does not pierce a retina of the eye when the needle is advanced from the distal end of the flexible cannula.

6. The method of claim 1 , wherein the fluid is located in the subretinal space of the eye before the act of inserting the flexible cannula is performed.

7. The method of claim 1 , wherein the fluid is located in the subretinal space of the eye before the act of advancing the needle is performed.

8. The method of claim 1 , wherein the fluid is located in the subretinal space due to a retinal detachment that occurred before the act of inserting the flexible cannula is performed.

9. The method of claim 1 , wherein the fluid is located in the subretinal space due to a macular hemorrhage that occurred before the act of inserting the flexible cannula is performed.

10. The method of claim 1 , further comprising injecting the fluid into the subretinal space of the eye, wherein the act of injecting the fluid causes a substantial portion of the retina to detach from the choroid.

11. The method of claim 10 , wherein the act of injecting the fluid is performed after the act of advancing the needle, wherein the fluid is injected via the needle.

12. The method of claim 10 , wherein the fluid comprises a balanced salt solution.

13. The method of claim 10 , wherein the act of injecting the fluid into the subretinal space comprises injecting a first volume of fluid into the subretinal space, wherein the act of injecting a therapeutic agent into the subretinal space comprises injecting a second volume of fluid into the subretinal space, wherein the first volume is larger than the second volume.

14. The method of claim 13 , wherein the act of aspirating fluid from the subretinal space comprises aspirating the first volume of fluid.

15. The method of claim 13 , wherein the first volume is in the range of approximately 150 μL to approximately 400 μL, wherein the second volume is in the range of approximately 25 μL to approximately 200 μL.

16. A method, comprising:

(a) inserting a flexible cannula between a sclera and a choroid of an eye in an anterior region of the eye;

(b) after a distal end of the flexible cannula reaches a posterior region of the eye, advancing a needle from the distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye;

(c) injecting a first volume of bleb fluid into the subretinal space via the needle;

(d) aspirating at least some of the first volume of bleb fluid from the subretinal space via the needle; and

(e) after aspirating at least some of the first volume of bleb fluid from the subretinal space via the needle, injecting a second volume of therapeutic agent into the subretinal space via the needle, wherein the second volume is smaller than the first volume.

17. A method, comprising:

(a) performing a sclerotomy in an anterior region of a sclera of an eye to thereby form an incision through the sclera;

(b) inserting a flexible cannula through the incision into a space between the sclera and a choroid of the eye such that the flexible cannula is oriented tangentially relative to the incision;

(c) advancing the flexible cannula within the space to position a distal end of the flexible cannula at a posterior region of a retina of the eye on an opposite side of the choroid from the retina;

(d) advancing a needle from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye;

(e) aspirating a first fluid from the subretinal space via the needle, and

(f) after aspirating the first fluid from the subretinal space via the needle, injecting a second fluid into the subretinal space via the needle.

18. The method of claim 1 , wherein the act of aspirating fluid from the subretinal space is performed with the needle at a first location in the subretinal space, wherein the act of injecting a therapeutic agent into the subretinal space is performed with the needle at the first location.

19. The method of claim 1 , wherein the act of aspirating fluid from the subretinal space comprises aspirating bleb fluid from the subretinal space.

20. The method of claim 1 , further comprising after injecting the therapeutic agent into the subretinal space, removing the flexible cannula from the space between the sclera and the choroid of the eye.

Assignments (12)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2024
From: F. HOFFMANN-LA ROCHE AG
To: GENENTECH, INC.
Reel/Frame 069097/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2024
From: GYROSCOPE THERAPEUTICS LIMITED
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 069092/0131 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNOR SHOULD READ "ORBIT BIOMEDICAL LIMITED" PREVIOUSLY RECORDED ON REEL 053762 FRAME 0437. ASSIGNOR(S) HEREBY CONFIRMS THE THE ORIGINAL READ "ORBIT BIOMEDICAL LIMTED". Recorded Sep 23, 2020
From: ORBIT BIOMEDICAL LIMITED
To: GYROSCOPE THERAPEUTICS LIMITED
Reel/Frame 053856/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: ORBIT BIOMEDICAL LIMTED
To: GYROSCOPE THERAPEUTICS LIMITED
Reel/Frame 053762/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: SAEC/KINETIC VISION, INC.
To: JANSSEN BIOTECH, INC.
Reel/Frame 046187/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: KHAN, ISAAC J.; KEANE, MICHAEL F.
To: JANSSEN BIOTECH, INC.
Reel/Frame 046187/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: KO, BENJAMIN L.
To: KALEIDOSCOPE ANIMATIONS, INC. D/B/A KALEIDOSCOPE, INC.
Reel/Frame 046187/0983 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: KALEIDOSCOPE, INC.
To: JANSSEN BIOTECH, INC.
Reel/Frame 046188/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: JANSSEN BIOTECH, INC.
To: ORBIT BIOMEDICAL LIMITED
Reel/Frame 046189/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: PRICE, DANIEL W.; OBERKIRCHER, BRENDAN J.
To: ETHICON LLC
Reel/Frame 046187/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: ETHICON LLC
To: JANSSEN BIOTECH, INC.
Reel/Frame 046187/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2018
From: PRENGER, DANIEL J.; KING, GEOFFREY
To: SAEC/KINETIC VISION, INC.
Reel/Frame 046187/0540 →